Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05977322 |
Title | A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors. |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Novartis Pharmaceuticals |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | NLD | ITA | ISR | ESP | CHE |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Stanford University . | Palo Alto | California | 94304 | United States | Details | |
Massachusetts General Hospital Massachusetts General Hospital | Boston | Massachusetts | 02114 | United States | Details | |
BAMF Health Research | Grand Rapids | Michigan | 49503 | United States | Details | |
MD Anderson Cancer Center Uni of Te MDACC. | Houston | Texas | 77030 | United States | Details | |
Novartis Investigative Site | Tel Aviv | 6423906 | Israel | Details | ||
Novartis Investigative Site | Reggio Emilia | RE | 42123 | Italy | Details | |
Novartis Investigative Site | Nijmegen | 6500HB | Netherlands | Details | ||
Novartis Investigative Site | Hospitalet de LLobregat | Catalunya | 08907 | Spain | Details | |
Novartis Investigative Site | Madrid | 28034 | Spain | Details | ||
Novartis Investigative Site | Geneve 14 | CH 1211 | Switzerland | Details |